Home › Funds › ACT Capital Partners, L.P. › KZIA
ACT Capital Partners, L.P. position in KZIA
KAZIA THERAPEUTICS LTD · Health Care
ACT Capital Partners, L.P. reported holding 35,000 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$336K, representing 0.23% of its reported portfolio and ranking #40 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s KZIA position evolved
ACT Capital Partners, L.P. first disclosed a stake in KZIA in Q3 2026 at 35,000 shares (US$336K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 35.00K | $335.82K | New |
About KZIA and 13F data
KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 43 other funds we track also report a position in KZIA — the largest reported positions include Boxer Capital Management, LLC (US$7.9M), Bleichroeder LP (US$5.6M), Ikarian Capital, LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KZIA
- Boxer Capital Management, LLC 560.00K sh · $7.88M · Q2 2026
- Bleichroeder LP 400.00K sh · $5.63M · Q2 2026
- Ikarian Capital, LLC 396.20K sh · $5.58M · Q2 2026
- Dauntless Investment Group, LLC 354.21K sh · $4.99M · Q2 2026
- Stonepine Capital Management, LLC 345.18K sh · $4.86M · Q2 2026
- COOPERMAN LEON G 50.00K sh · $704.00K · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held KZIA?
ACT Capital Partners, L.P. has disclosed KZIA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in KZIA?
As of Q3 2026, ACT Capital Partners, L.P. holds 35.00K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $335.82K, representing 0.23% of its reported portfolio and ranking #40.
Has ACT Capital Partners, L.P. been buying or selling KZIA?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in KZIA.
Which other funds hold KZIA?
Other major institutional holders of KZIA include Boxer Capital Management, LLC, Bleichroeder LP, Ikarian Capital, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.